Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
NCT04396873Phase 1Recruiting
- Sponsor
- National Institute of Mental Health
- Start
- Aug 2021
- Primary completion
- Apr 2029
- Modality
- Alpha Emitters, Beta Emitters, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [11C]MC1 and [11C]PS13, sponsored by National Institute of Mental Health. Primary endpoint: Measurement of COX-1 and COX-2 density in brain. Started Aug 2021; status: recruiting.
02
Drugs
[11C]MC1[11C]PS13
Beyond the preview
Go deeper on NCT04396873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04396873.